HB
Human Biotech, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise6count reported to the SEC
FiledJun 3, 2026first sale May 22, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Errik B. AndersonDirector
Andrew B. DanielsenDirector
Agustin Javier Lopez-MarquezExecutive Officer, Director, Promoter
Dusan B. PerovicDirector
Ankit B. SaxenaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.